Webinar

EU HTA – Achieving broad access fast! What will it take for innovative medicines to succeed?

Healthcare in Europe prepares for the EU HTA. Join our discussion on recent national reforms and essential policies to accelerate patient access to groundbreaking medicines.

Watch the webinar

Anticipating the imminent launch of the joint clinical assessment (JCA) in January 2025, the healthcare industry in Europe is preparing for a transformative shift in how innovations are evaluated and approved. Considering the recent national reforms across Europe, our expert panel will comment on the evolving landscape.

Watch the recording of our panel discussion hosted by Evidence Base and discover the essential healthcare system requirements and policies crucial for accelerating patient access to groundbreaking medicines.

Moderator

Herbert Altmann

Vice President, Market Access & Healthcare Consulting Europe, Cencora

Speaker

Iga Lipska

Chairwoman of the Board, Health Policy Institute Poland

Speaker

François Meyer

Independent Consultant

Speaker

Oriol Solà-Morales

CEO, Health Innovation Technology Transfer

What will you learn?

Critical success factors for the EU HTA Regulation implementation
Strategies to leverage JCA reports while ensuring broad patient access across Europe
Recommendations for collaboration among member states, healthcare systems, and industry stakeholders
How the new JCA will impact healthcare delivery and innovation